Patents Represented by Attorney Samuel Kais
  • Patent number: 7550492
    Abstract: Certain amidophenyl-sulfanylamino-benzo[1,2,5]thiadiazole compounds are CCK2 modulators useful in the treatment of CCK2 mediated diseases.
    Type: Grant
    Filed: July 10, 2007
    Date of Patent: June 23, 2009
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Brett Allison, Laura C. McAfee, Victor K. Phuong, Michael H. Rabinowitz, Nigel P. Shankley